01643oam 2200481 450 991070837600332120180221145754.0(CKB)3460000000111867(OCoLC)852784181(OCoLC)651846829(OCoLC)778279908(OCoLC)1011783160(EXLCZ)99346000000011186720130713d2002 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierAn inquiry into the ImClone cancer-drug story hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002Washington :U.S. Government Printing Office,2002.1 online resource (iii, 759 pages) illustrations"Serial No. 107-142."Includes bibliographical references.Inquiry into the ImClone cancer-drug story CetuximabTestingDrugsUnited StatesTestingInsider trading in securitiesUnited StatesCetuximabTesting.DrugsTesting.Insider trading in securitiesOCLCEOCLCEOCLCOOCLCAOCLCQOCLCOOCLCQNJRGPOOCLCQGPOBOOK9910708376003321An inquiry into the ImClone cancer-drug story3523078UNINA